Stimulation of human or rabbit platelets with thrombin in the presence of fibrinogen caused a large decrease, compared with unstimulated controls, in the amount of phosphatidylinositol 4,5-bisphosphate (PIP2) that could be extracted with acidified chloroform/methanol (60% at 60 s). In contrast, stimulation in the absence of added fibrinogen increased the amount of PIP2. The decrease was specific for PIP2, because similar decreases could not be demonstrated for other phosphoinositides or phospholipids. The interaction ofpolymerizing fibrin with stimulated platelets was required for the decrease in PIP2, since polymerized fibrin formed by reptilase did not cause the decrease in the amount of extractable PIP2, and inhibition by glycyl-L-prolyl-L-arginyl-L-proline of polymerization of fibrin formed by the action of thrombin prevented the large decrease in extractable PIP2. The decrease in extractable PIP2 could not be explained by increased degradation of PIP2, since sufficient degradation products were not formed. Thus, when platelets are stimulated with thrombin in the pres,nce of fibrinogen, an association of polymerizing fibrin with the stimulated platelets occurs that leads to decreased extractability of PIP2. This may mean that PIP2 forms a specific association with platelet proteins that are involved in clot retraction.
INTRODUCTION
Membrane lipids in cells can associate with cellular proteins, including the cytoskeleton (Anderson & Marchesi, 1985; Burn et al., 1985; Ferguson et al., 1985; Futerman et al., 1985; Lassing & Lindberg, 1985; Low & Finean, 1977 Meyer et al., 1982; Schick et al., 1983) . Low et al. (1986) have proposed that the enzymes which are released from the surface of various types of cells by pI-specific phospholipase C may be covalently attached to PL, which serves as their membrane attachment site. For platelets, there is evidence of association of membrane lipids with protein when the platelets are stimulated with thrombin (Burn et al., 1985; Schick et al., 1983) . Lassing & Lindberg (1985) have described a specific interaction between PIP2 and profilactin which promotes the dissociation of the profilactin complex, leaving a profilin-PIP2 complex and freeing actin, which then polymerizes.
In studies of human and rabbit platelets stimulated with thrombin in the presence of fibrinogen, we have found an unexpectedly large decrease in the amount of PIP2 that can be recovered by extraction with acidified chloroform/methanol. Thrombin stimulates platelets to change shape, aggregate and secrete the contents of their storage granules, as well as converting fibrinogen into fibrin. Retraction of the platelet-fibrin clot follows, the mechanical force being provided by the contractile system of the platelets. The interaction of platelets with polymerizing fibrin is a key -step in clot retraction and consolidation of haemostatic plugs.
To examine the reason for the decreased recovery of PIP2 from platelets stimulated with thrombin in the presence of fibrinogen, we have examined whether the decrease is due to (1) inaccessibility to extracting solvents of platelet membranes in the centre of the clot (Zucker & Masiello, 1983) , by comparing PIP2 extraction with that of other phospholipids, (2) increased degradation of PIP2 by phospholipase C, by measuring formation of IP3, (3) non-specific association of PIP2 with protein during extraction, which prevents its extraction, or (4) a specific association of PIP2 with platelet protein as a result of platelet stimulation and interaction with polymerized fibrin, which prevents its extraction.
METHODS

Platelet preparation
Human platelets from whole blood, taken from the forearm vein into ACD (Aster & Jandl, 1964) , were washed once in Tyrode solution containing heparin (50 units/ml), albumin (0.35 %), glucose (0.1%) and apyrase . After centrifugation, the platelets were resuspended in a modified Tyrode solution containing albumin, glucose and apyrase, from which phosphate was omitted; buffering was provided by the addition of 5 mM-Hepes. Rabbit platelets were collected and resuspended in a Ca2+-and phosphate-free Tyrode solution (containing albumin, glucose, apyrase and 5 mm-Hepes) as previously described (Vickers et al., 1982) . Studies 
The human platelets were freed of unincorporated label by centrifugation and resuspension in Tyrode solution (containing phosphate, albumin, glucose and apyrase). Rabbit platelets were freed of unincorporated label by centrifugation and resuspension in Ca2+-free Tyrode solution containing phosphate. In both cases, the platelets were finally resuspended in Tyrode solution [containing albumin (0.35%), glucose (0.1%) and apyrase] at 109 platelets/ml. The platelets were stimulated with thrombin while being stirred in a cuvette in an aggregometer (Payton Associates, Scarborough, Ont., Canada), and 1 ml of reaction mixture was extracted with 3.75 ml of chloroform/methanol (1:2, v/v), followed by extraction with acidified chloroform/methanol as previously described (Vickers et al., 1982) . The chloroform phases were combined and the phospholipids were fractionated on silica-gel H t.l.c. plates (Canlab, Toronto, Ont., Canada) in two dimensions (Vickers et al., 1982) . The lipids were localized by viewing the plates under u.v. light after spraying with Rhodamine 6G and by autoradiography. The spots containing the phospholipids were scraped from the plates, and the phospholipids were digested with HC104. After addition of water, and centrifugation (1000 g for 10 min), samples of the supernatant were removed for determination of Pi and incorporated label, as previously described (Vickers et al., 1982) . To quantify the label that was not in the chloroform phases, the aqueous/methanol phase, including the protein interface, was centrifuged (250 g for 10 min) after removal of the chloroform phase. Portions of the aqueous/methanol phase (200,u) were removed and dried in scintillation vials for counting after addition of ACS (Amersham/Searle, Mississauga, Ont., Canada) cocktail. The remaining aqueous/methanol phase was then removed and the protein solubilized with NCS (Amersham/Searle), transferred to scintillation vials and counted for radioactivity in ACS cocktail.
Studies of changes in inositol labelling of phospholipids and inositol phosphates in thrombin-or ADP-stimulated rabbit platelets
For determination of labelling of the phosphoinositides and inositol phosphates, the platelets were prelabelled as described in the previous section, except that [3H]inositol (20 ,uCi/ml; American Radiolabeled Chemicals, St. Louis, MO, U.S.A.) was included with the [32P]P1. Phosphoinositide extraction and fractionation were done as described above.
For inositol phosphate studies, the platelets were incubated with 20 mM-Li+ for 1 h after labelling; Li+ blocks degradation of the inositol phosphates to inositol and phosphate. Inositol phosphates were extracted with 10% trichloroacetic acid and fractionated on ionexchange columns [AGI-X8; Bio-Rad Laboratories (Canada), Mississauga, Ont., Canada] as previously described (Vickers et al., 1984) .
The data are presented as means + S.E.M. and the significance of the data was assessed by paired t-test analysis.
RESULTS
Stimulation of human platelets with thrombin for 10 s in the presence of fibrinogen decreased the amount of extractable PIP2 by 32% (P < 0.01, n = 6), compared with an 11 % decrease (P < 0.01, n = 6) in the absence of fibrinogen. As shown in Table 1 , the decrease was even greater by 60 s. In platelets stimulated with thrombin in the presence of fibrinogen, PIP2 decreased by 60%, whereas in the absence of fibrinogen the initial decrease in amount of extractable PIP2 was replaced by an increase in amount to approx. 123% of the control value. To account for the disappearance of PIP2, the label which remained in the aqueous/methanol phase and the protein interface was determined in experiments with platelets prelabelled with [3H]inositol. The isolated protein precipitate from platelets stimulated with thrombin in the absence of fibrinogen contained 6942+ 1236 d.p.m./109 platelets. In contast, the radioactivity in the protein precipitate was increased by approx. 4300 d.p.m. in platelets stimulated in the presence of fibrinogen (11216+ 1628 d.p.m./109 platelets; n = 2). There was no increase in the amount of label in the aqueous/methanol phase in the presence of fibrinogen compared with that in its absence. The extraction of PIP2 was then compared with that of the other phospholipids from platelets stimulated with thrombin in the absence and in the presence of fibrinogen. In the absence or the presence of fibrinogen, stimulation of the platelets with thrombin did not significantly change the amount of extractable PIP (Table 1 ). The decrease in amount of PI and the increases in amount of PA in thrombin-stimulated platelets were similar in the absence or the presence of fibrinogen (Table 1 ). The amount of extractable PC was not significantly changed by stimulation of the platelets with thrombin in either the absence or the presence of fibrinogen (Table 1) .
Thrombin stimulation of rabbit platelets in the presence of fibrinogen had an effect, similar to the effect of stimulation of human platelets, on the amounts of PIP2 that were extracted ( Table 2 ). As indicated in Table   3 , the amount of label recovered in PIP2 in platelets stimulated in the presence of fibrinogen was also decreased compared with platelets stimulated in the absence of fibrinogen (by 5218 platelets, n = 6). There was no increase in the amount of label in the aqueous/methanol phase in the presence of fibrinogen compared with that in its absence. Since the other phospholipids examined were recovered in the same amounts in the presence or the absence of fibrinogen with both human and rabbit platelets, the failure to extract PIP2 after stimulation of platelets with thrombin in the presence of fibrinogen is unlikely to be due to failure to remove phospholipid from the core of the platelet-fibrin clot.
In contrast with thrombin-stimulated platelets, the presence of fibrinogen had no significant effect on the recovery of PIP2 from ADP-stimulated platelets. Stimulation of rabbit platelets with 10 ,M-ADP in the absence of added fibrinogen resulted in a decrease in the amount of PIP2, by'0.33 nmol/109 platelets. ADP stimulation in (Laudano & Doolittle, 1978) and thereby prevents formation of a platelet-fibrin clot. GPRP (0.4 mM) does not abolish binding of fibrin monomers to platelets or platelet aggregation (Harfenist et al., 1985) . In the present experiments, GPRP prevented the large decrease in amount ofextractable PIP2 when human platelets were stimulated with thrombin for 60 s in the presence of fibrinogen (the amount of PIP2 recovered from control samples with fibrinogen and GPRP was 3.68 + 0.07 nmol/109 platelets; from thrombin-stimulated platelets in the presence of fibrinogen and GPRP, 4.37 + 0.30 nmol/ 109 platelets; n = 4). These findings in the presence of GPRP are similar to those obtained with platelets stimulated with thrombin in the absence of added fibrinogen (Table 1) . GPRP alone had no effect on the amount of PIP2 recovered from platelets stimulated with thrombin in the absence of fibrinogen (n = 4). Thus the association of stimulated platelets with polymerizing fibrin in a platelet-fibrin clot appears to be required for the retention of PIP2.
Another explanation for the failure to extract PIP2 Table 3 . Effect of stimulating washed rabbit platelets with 1 unit of thrombin/ml of suspension for 60 s in the absence and presence of fibrinogen (0.4 mg/ml) on the amount of label in the extractable phosphoinositides and their derivatives
The results are presented as means + S.E.M. (n = 4), with the differences (A) in labelling between samples incubated with Tyrode solution and samples treated with thrombin. The differences between the thrombin-induced changes in PIP2 and IP3 in the absence and presence of fibrinogen were the only such differences that were statistically significant. Platelet preparation, labelling and determination of labelling of the phosphoinositides and inositol phosphates are described in the Methods section. The data for the inositol phosphates and the data for the phospholipids were obtained in separate experiments.
[ To assess whether or not the decrease in recovery of PIP2 could be due to increased degradation of PIP2 to IP3, the changes in [3H]inositol labelling of the phosphoinositides and other inositol-containing species recovered from the platelets were determined in platelets stimulated with thrombin in the absence and presence of fibrinogen. The decrease in extractable PIP2 in platelets stimulated with thrombin in the presence of fibrinogen could not be accounted for by increased formation of the inositol phosphates (Table 3) . These data, and the observation that thrombin stimulation of platelets in the presence of fibrinogen did not cause a larger increase in PA than did stimulation in the absence of fibrinogen (Tables 1 and 2 ), indicate that degradation of PIP2 by phospholipase C had not been increased. The absence of an increase in PIP large enough to account for the decrease in PIP2 (Tables 1 and 2) indicates that increased degradation of PIP2 by phosphomonoesterase or decreased synthesis of PIP2 from PIP cannot account for the large decrease in PIP2. The sum of the changes in labelling of the inositol-containing species in the platelets stimulated in the presence of fibrinogen is about 4400 d.p.m./109 platelets less than in platelets stimulated in the absence of fibrinogen. Thus these results are consistent with the hypothesis that the decrease is mainly due to failure to extract PIP2. Although the lysophosphoinositides were not quantified and thus not included in this accounting, there was no evidence from the autoradiograms that the labelling of these species was changed by the presence of fibrinogen during thrombin stimulation of the platelets.
DISCUSSION
The results of these experiments demonstrate that stimulation of human or rabbit platelets with thrombin in the presence of fibrinogen results in the formation of a platelet-fibrin clot and in a decrease in the amount of PIP2 that can be extracted that is much larger then the decrease caused by degradation of PIP2 to IP3 by phospholipase C. This is specific for PIP2, since the other phospholipids examined can be recovered in the same amounts in the presence of fibrinogen as in its absence. The thrombin-stimulated changes in extractable PIP2 found in the absence of fibrinogen are similar to changes reported by others (Billah & Lapetina, 1982; Broekman, 1984; Holmsen et al., 1984; Perret et al., 1983; Rendu et al., 1983; Wilson et al., 1985) . The observations that PIP2 can be extracted from unstimulated platelets in the presence of fibrinogen, or from unstimulated platelets 1987 652 r 5 I exposed to polymerizing fibrin formed by reptilase, and that PIP2 can be extracted from thrombin-stimulated platelets when polymerization of fibrin is blocked by GPRP, indicate that the failure to extract PIP2 is unlikely to be due to non-specific association of the PIP2 with protein in the extraction mixture. These observations, and the observation that ADP stimulation of rabbit platelets in the presence of fibrinogen did not decrease recovery of PIP2, although ADP-stimulated platelets are known to bind fibrinogen (Mustard et al., 1978) , are consistent with the retention of PIP2 in thrombinstimulated platelets requiring interaction ofpolymerizing fibrin with stimulated platelets. There is no evidence of increased PIP2 degradation by one of its usual metabolic pathways, since there was no increase in the amounts of PIP, PI, PA, IP3, IP2, IP or the lysophosphoinositides to account for the decrease in PIP2. A possible explanation of the results is that the PIP2 specifically associates with platelet proteins, so that very little can be extracted. Whether or not this association is similar to the PIP2-profilactin association reported by Lassing & Lindberg (1985) is not known. Since GPRP prevented retention of PIP2 in human platelets stimulated with thrombin in the presence of fibrinogen, and since monomeric fibrin binds to platelets in the presence of GPRP at the concentration used in the present experiments (Harfenist et al., 1985) , this may mean that polymerizing fibrin has an additional form of association with the platelet membrane compared with monomeric fibrin and that this involves PIP2 and platelet proteins [possibly cytoskeletal proteins, since there are major changes in the associations among these proteins when platelets are stimulated with thrombin (Fox, 1985) ].
